Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 26 | 2024 | 6915 | 2.460 |
Why?
|
| Psychotic Disorders | 10 | 2024 | 3175 | 1.720 |
Why?
|
| Evoked Potentials, Auditory | 5 | 2019 | 529 | 1.490 |
Why?
|
| Lateral Ventricles | 3 | 2021 | 146 | 1.160 |
Why?
|
| Cannabis | 2 | 2023 | 436 | 1.080 |
Why?
|
| Event-Related Potentials, P300 | 5 | 2020 | 149 | 0.910 |
Why?
|
| Corpus Callosum | 2 | 2019 | 749 | 0.850 |
Why?
|
| Affective Disorders, Psychotic | 2 | 2021 | 186 | 0.830 |
Why?
|
| Marijuana Abuse | 1 | 2022 | 411 | 0.620 |
Why?
|
| Attention | 2 | 2014 | 2386 | 0.450 |
Why?
|
| Language | 2 | 2021 | 1532 | 0.440 |
Why?
|
| Nerve Net | 2 | 2021 | 2258 | 0.390 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 503 | 0.370 |
Why?
|
| Disease Progression | 5 | 2021 | 13505 | 0.360 |
Why?
|
| Mental Health | 2 | 2022 | 3206 | 0.360 |
Why?
|
| Electroencephalography | 9 | 2020 | 6182 | 0.350 |
Why?
|
| Evoked Potentials, Visual | 3 | 2020 | 415 | 0.330 |
Why?
|
| Psychiatry | 1 | 2021 | 1686 | 0.330 |
Why?
|
| Bipolar Disorder | 2 | 2024 | 5077 | 0.330 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2019 | 2383 | 0.330 |
Why?
|
| Cerebral Cortex | 3 | 2024 | 5755 | 0.310 |
Why?
|
| Schizophrenic Psychology | 3 | 2022 | 1646 | 0.280 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 621 | 0.270 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2007 | 301 | 0.270 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1876 | 0.270 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 4547 | 0.260 |
Why?
|
| Activin Receptors | 1 | 2004 | 40 | 0.240 |
Why?
|
| Brain | 9 | 2024 | 26912 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 36247 | 0.240 |
Why?
|
| Silymarin | 1 | 2024 | 45 | 0.240 |
Why?
|
| Cathepsins | 3 | 2007 | 242 | 0.240 |
Why?
|
| Inhibins | 1 | 2004 | 209 | 0.230 |
Why?
|
| Activin Receptors, Type I | 1 | 2004 | 136 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2018 | 8945 | 0.210 |
Why?
|
| Cysteine Endopeptidases | 3 | 2007 | 548 | 0.210 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2024 | 448 | 0.200 |
Why?
|
| Young Adult | 17 | 2024 | 58673 | 0.190 |
Why?
|
| Social Adjustment | 1 | 2023 | 632 | 0.180 |
Why?
|
| Risk | 5 | 2021 | 9629 | 0.180 |
Why?
|
| Proteoglycans | 1 | 2004 | 802 | 0.180 |
Why?
|
| Neurofeedback | 1 | 2020 | 44 | 0.170 |
Why?
|
| DiGeorge Syndrome | 1 | 2021 | 185 | 0.170 |
Why?
|
| Nigeria | 1 | 2021 | 762 | 0.160 |
Why?
|
| Endophenotypes | 2 | 2017 | 255 | 0.160 |
Why?
|
| Ketamine | 1 | 2024 | 516 | 0.160 |
Why?
|
| Male | 27 | 2024 | 359413 | 0.150 |
Why?
|
| Humans | 37 | 2024 | 760261 | 0.150 |
Why?
|
| Organ Size | 3 | 2018 | 2249 | 0.150 |
Why?
|
| Aptitude | 1 | 2017 | 43 | 0.150 |
Why?
|
| Evoked Potentials | 2 | 2014 | 1031 | 0.140 |
Why?
|
| Acoustic Stimulation | 2 | 2019 | 1232 | 0.140 |
Why?
|
| Hallucinations | 1 | 2020 | 366 | 0.140 |
Why?
|
| Female | 25 | 2024 | 391011 | 0.140 |
Why?
|
| Universities | 1 | 2021 | 983 | 0.130 |
Why?
|
| Genetic Linkage | 1 | 2021 | 2381 | 0.130 |
Why?
|
| Schools, Medical | 1 | 2021 | 878 | 0.120 |
Why?
|
| Europe | 1 | 2021 | 3433 | 0.120 |
Why?
|
| Social Perception | 1 | 2018 | 431 | 0.110 |
Why?
|
| Cell-Free System | 2 | 2004 | 341 | 0.110 |
Why?
|
| Adult | 19 | 2024 | 219847 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 3335 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2016 | 6242 | 0.100 |
Why?
|
| Intelligence | 1 | 2017 | 919 | 0.100 |
Why?
|
| Acute Disease | 3 | 2018 | 7268 | 0.100 |
Why?
|
| Outpatients | 1 | 2019 | 1606 | 0.100 |
Why?
|
| Semantics | 2 | 2012 | 599 | 0.090 |
Why?
|
| Cognition | 3 | 2018 | 6948 | 0.090 |
Why?
|
| Glycosylation | 2 | 2004 | 1097 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2627 | 0.090 |
Why?
|
| Adolescent | 9 | 2021 | 87747 | 0.090 |
Why?
|
| Hippocampus | 1 | 2023 | 3737 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39254 | 0.090 |
Why?
|
| Phenotype | 2 | 2024 | 16543 | 0.080 |
Why?
|
| Crystallography, X-Ray | 2 | 2004 | 1979 | 0.080 |
Why?
|
| Sex Factors | 1 | 2023 | 10530 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 3800 | 0.080 |
Why?
|
| Executive Function | 1 | 2017 | 1370 | 0.080 |
Why?
|
| Mood Disorders | 1 | 2014 | 1123 | 0.070 |
Why?
|
| Speech Perception | 1 | 2012 | 505 | 0.070 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2212 | 0.070 |
Why?
|
| Brain Mapping | 4 | 2020 | 6562 | 0.070 |
Why?
|
| Ligands | 2 | 2004 | 3277 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2014 | 1197 | 0.070 |
Why?
|
| Dynamins | 1 | 2007 | 138 | 0.070 |
Why?
|
| Receptors, Vasopressin | 1 | 2007 | 106 | 0.070 |
Why?
|
| Kinetics | 2 | 2004 | 6378 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 25928 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 18134 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2007 | 382 | 0.060 |
Why?
|
| Follistatin-Related Proteins | 1 | 2004 | 48 | 0.060 |
Why?
|
| Proteinuria | 1 | 2007 | 594 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2018 | 6017 | 0.060 |
Why?
|
| Affect | 1 | 2012 | 1479 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17766 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2000 | 8498 | 0.060 |
Why?
|
| Follistatin | 1 | 2004 | 136 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3976 | 0.050 |
Why?
|
| Cathepsin H | 2 | 2000 | 10 | 0.050 |
Why?
|
| Podocytes | 1 | 2007 | 402 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 613 | 0.050 |
Why?
|
| Albuminuria | 1 | 2007 | 659 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2000 | 6855 | 0.050 |
Why?
|
| Software | 1 | 2016 | 4420 | 0.050 |
Why?
|
| Iodine | 1 | 2004 | 286 | 0.050 |
Why?
|
| Luciferases | 1 | 2004 | 716 | 0.050 |
Why?
|
| Memory | 1 | 2012 | 2179 | 0.050 |
Why?
|
| Risperidone | 1 | 2024 | 379 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1746 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 1066 | 0.050 |
Why?
|
| Cell Line | 3 | 2007 | 15626 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10829 | 0.050 |
Why?
|
| Protein Binding | 2 | 2004 | 9336 | 0.050 |
Why?
|
| Middle Aged | 12 | 2024 | 220175 | 0.050 |
Why?
|
| Lysosomes | 1 | 2007 | 919 | 0.050 |
Why?
|
| Receptors, Fc | 1 | 2004 | 534 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 598 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1993 | 0.040 |
Why?
|
| Emotions | 1 | 2012 | 2730 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2004 | 1531 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 988 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2007 | 3735 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1697 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2018 | 7016 | 0.040 |
Why?
|
| Functional Laterality | 2 | 2018 | 2253 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 14482 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4172 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 15766 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2024 | 961 | 0.040 |
Why?
|
| Child | 2 | 2023 | 79758 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 1956 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2000 | 657 | 0.030 |
Why?
|
| Meditation | 1 | 2020 | 251 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2024 | 1861 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2007 | 2093 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2004 | 5039 | 0.030 |
Why?
|
| Reaction Time | 2 | 2013 | 2075 | 0.030 |
Why?
|
| Photic Stimulation | 2 | 2013 | 1968 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3448 | 0.030 |
Why?
|
| Rest | 1 | 2020 | 915 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 6543 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2018 | 2776 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2004 | 3683 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1635 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2007 | 4938 | 0.030 |
Why?
|
| Cathepsin L | 2 | 2007 | 68 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1997 | 772 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 3107 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2000 | 3618 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2852 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1490 | 0.020 |
Why?
|
| Pitch Perception | 1 | 2012 | 101 | 0.020 |
Why?
|
| Anisotropy | 1 | 2015 | 1278 | 0.020 |
Why?
|
| Kidney | 1 | 2007 | 7072 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17628 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 3061 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2000 | 4127 | 0.020 |
Why?
|
| Mice | 4 | 2024 | 81216 | 0.020 |
Why?
|
| Association Learning | 1 | 2012 | 219 | 0.020 |
Why?
|
| Delusions | 1 | 2012 | 298 | 0.020 |
Why?
|
| Self-Assessment | 1 | 2012 | 393 | 0.020 |
Why?
|
| Psychopathology | 1 | 2012 | 427 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2012 | 22041 | 0.020 |
Why?
|
| Animals | 6 | 2024 | 167940 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6361 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2000 | 11141 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 3613 | 0.020 |
Why?
|
| Models, Biological | 1 | 2004 | 9468 | 0.020 |
Why?
|
| Cues | 1 | 2012 | 867 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2018 | 3039 | 0.020 |
Why?
|
| Streptozocin | 1 | 2007 | 193 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2007 | 127 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2363 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 11064 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 458 | 0.020 |
Why?
|
| Yeasts | 1 | 2007 | 279 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2007 | 150 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 8553 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 565 | 0.020 |
Why?
|
| Gonads | 1 | 2004 | 109 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7803 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2004 | 169 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58947 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2004 | 278 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12959 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2007 | 1090 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2473 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1167 | 0.010 |
Why?
|
| Random Allocation | 1 | 2007 | 2394 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2007 | 18968 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 23363 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1109 | 0.010 |
Why?
|
| Actins | 1 | 2007 | 2049 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5782 | 0.010 |
Why?
|
| Aging | 1 | 2018 | 8641 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12156 | 0.010 |
Why?
|
| Gelatinases | 1 | 1997 | 88 | 0.010 |
Why?
|
| Cathepsin B | 1 | 1997 | 80 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 5902 | 0.010 |
Why?
|
| Collagenases | 1 | 1997 | 221 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 168995 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8157 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 1997 | 394 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 1997 | 462 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1997 | 633 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 40133 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 23695 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 29950 | 0.000 |
Why?
|
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_